Epidemiological profile of gestational and congenital toxoplasmosis cases arising out of the population outbreak

Keywords: toxoplasmosis congenital, pregnancy, epidemiology

Abstract

Objective: To trace the epidemiological profile of cases of gestational and congenital toxoplasmosis reported in the city of Santa Maria - RS, resulting from the outbreak that occurred in 2018 and to investigate the association between maternal variables and the baby’s diagnosis.
Method: Cases reported between March 2018 and March 2019 were retrospectively evaluated. The baby’s diagnosis and maternal variables were analyzed using descriptive statistics and chi-square test.
Results: During the study period, 206 cases of gestational toxoplasmosis were reported, of which 74 were confirmed as a recent infection. Vertical transmission was confirmed in 27% of cases. There was a higher frequency of transmission in pregnant women who were diagnosed in the third trimester of pregnancy (p = 0.001) and who did not undergo treatment during pregnancy (p <0.001).
Conclusion: The occurrence of congenital toxoplasmosis is associated with late diagnosis, in the last trimester of pregnancy, and consequent lack of adequate treatment. In addition, there was a high prevalence of children infected by vertical transmission due to the outbreak, which reinforces the importance of prenatal care and attention to the need for adequate treatment and care during the development of infected children.

Downloads

Download data is not yet available.

Author Biographies

Natiele Camponogara Righi, Universidade Franciscana (UFN), Santa Maria, RS, Brasil; Universidade Federal de Santa Maria (UFSM), Santa Maria, RS, Brasil.

Mestre em Reabilitação Funcional pela Universidade Federal de Santa Maria (UFSM), em Santa Maria, RS, Brasil.

Letícia Hermes, Universidade Federal de Santa Maria (UFSM), Santa Maria, RS, Brasil.

Mestre em Ciências da Saúde pela Universidade Federal de Santa Maria (UFSM), em Santa Maria, RS, Brasil.

Júlia Danezi Piccini, Universidade Federal de Santa Maria (UFSM), Santa Maria, RS, Brasil.

Pediatra pelo Hospital Universitário de Santa Maria (HUSM) e Universidade Federal de Santa Maria (UFSM), em Santa Maria, RS, Brasil.

Jerônimo Costa Branco, Universidade Franciscana (UFN), Santa Maria, RS, Brasil.

Doutor em Saúde e Comportamento pela Universidade Católica de Pelotas. Docente na Universidade Franciscana (UFN), em Santa Maria, RS, Brasil.

Jovito Adiel Skupien, Universidade Franciscana (UFN), Santa Maria, RS, Brasil.

Doutor em Odontologia pela Universidade Federal de Pelotas (UFPel). Docente na Universidade Franciscana (UFN), em Santa Maria, RS, Brasil.

Angela Regina Maciel Weinmann, Universidade Franciscana (UFN), Santa Maria, RS, Brasil; Universidade Federal de Santa Maria (UFSM), Santa Maria, RS, Brasil.

Doutora pela Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo (FMRP-USP). Docente na Universidade Franciscana (UFN) e na Universidade Federal de Santa Maria (UFSM), em Santa Maria, RS, Brasil.

Maria Clara da Silva Valadão, Universidade Franciscana (UFN), Santa Maria, RS, Brasil; Universidade Federal de Santa Maria (UFSM), Santa Maria, RS, Brasil.

Doutora em Medicina/Pediatria pela Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), em Porto Alegre, RS, Brasil. Docente na Universidade Franciscana (UFN) em Santa Maria, RS, Brasil.

Natielen Jacques Schuch, Universidade Franciscana (UFN), Santa Maria, RS, Brasil.

Doutora em Nutrição em Saúde Pública pela Faculdade de Saúde Pública da Universidade de São Paulo. Docente na Universidade Franciscana (UFN) em Santa Maria, RS, Brasil.

References

Guy EC. Toxoplasmosis. Medicine (Baltimore). 2014;42(1):31-3.

Kaye A. Toxoplasmosis: Diagnosis, Treatment, and Prevention in Congenitally Exposed Infants. J Pediatr Health Care. 2011;25(6):355-64. https://doi.org/10.1016/j.pedhc.2010.04.008

Kravetz JD, Federman DG. Toxoplasmosis in pregnancy. Am J Med. 2005;118:212-6. https://doi.org/10.1016/j.amjmed.2004.08.023

Singh S. Congenital toxoplasmosis: Clinical features, outcomes, treatment, and prevention. Trop Parasitol. 2016;6(2):113-22. https://doi.org/10.4103/2229-5070.190813

Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363:1965-76. https://doi.org/10.1016/s0140-6736(04)16412-x

Câmara JT, da Silva MG, de Castro AM. Prevalência de toxoplasmose em gestantes atendidas em dois centros de referência em uma cidade do Nordeste, Brasil. Rev Bras Ginecol Obstet. 2015;37(2):64-70. https://doi.org/10.1590/SO100-720320150005115

Varella IS, Wagner MB, Darela AC, Nunes LM, Müller RW. Prevalência de soropositividade para toxoplasmose em gestantes. J Pediatr (Rio J). 2003;79(1):69-74. https://doi.org/10.1590/S0021-75572003000100012

Spalding SM, Amendoeira MRR, Ribeiro LC, Silveira C, Garcia AP, Camilo-Coura L. Estudo prospectivo de gestantes e seus bebês com risco de transmissão de toxoplasmose congênita em município do Rio Grande do Sul. Rev Soc Bras Med Trop. 2003;36(4):483-91. https://doi.org/10.1590/S0037-86822003000400009

Neto EC, Amorim F, Lago EG. Estimation of the regional distribution of congenital toxoplasmosis in Brazil from the results of neonatal screening [Internet]. Sci Med (Porto Alegre). 2010 [citado 2021 Jul 10];20(1):64-70. Disponível em: https://revistaseletronicas.pucrs.br/ojs/index.php/scientiamedica/article/view/5983/4877

Maldonado YA, Read JS. Diagnosis, Treatment, and Prevention of Congenital Toxoplasmosis in the United States. Pediatrics. 2017;139(2):e20163860. https://doi.org/10.1542/peds.2016-3860

Rio Grande do Sul. Secretaria de Saúde. Alerta Epidemiológico. Toxoplasmose [Internet]. 2018 [citado 2021 Jul 10]. Disponível em: https://saude.rs.gov.br/upload/arquivos/carga20180752/25125245-09144313-09-05-18-alerta-toxoplamose.pdf

Jenum PA, Stray-Pedersen B, Gunderser A-G. Improved Diagnosis of Primary Toxoplasma gondii Infection in Early Pregnancy by Determination of Antitoxoplasma Immunoglobulin G Avidity. J Clin Microbiol. 1997;35(8):1972-7. https://doi.org/10.1128/jcm.35.8.1972-1977.1997

Figueiró-Filho EA, Lopes AHA, Senefonte FR de A, de Souza Júnior VG, Botelho CA, Figueiredo MS, et al. Toxoplasmose aguda: estudo da freqüência, taxa de transmissão vertical e relação entre os testes diagnósticos materno-fetais em gestantes em estado da Região Centro-Oeste do Brasil. Rev Bras Ginecol Obstet. 2005;27(8):442-9. https://doi.org/10.1590/S0100-72032005000800002

Avelar JB, da Silva MG, Rezende HHA, Storchilo HR, do Amaral WN, Xavier IR, et al. Epidemiological factors associated with Toxoplasma gondii infection in postpartum women treated in the public healthcare system of Goiânia, State of Goiás, Brazil. Rev Soc Bras Med Trop. 2018;51(1):57-62. https://doi.org/10.1590/0037-8682-0112-2017

Kapperud G, Jenum PA, Stray-pedersen B, Melby KK, Eskild A, Eng J. Risk Factors for Toxoplasma gondii Infection in Pregnancy: Results of a Prospective Case- Control Study in Norway. Am J Epidemiol. 1996;144(4):405-12. https://doi.org/10.1093/oxfordjournals.aje.a008942

Walcher DL, Comparsi B, Pedroso D. Toxoplasmose gestacional: uma revisão. RBAC. 2017;49(4):323-7. https://dx.doi.org/10.21877/2448-3877.201600273

Federação Brasileira das Associações de Ginecologia e Obstetrícia (FEBRASGO) Manual de Gestação de Alto Risco [Internet]. 2011 [citado 2021 Jul 10]; 220 p. disponível em: http://www.as.saude.ms.gov.br/wp-content/uploads/2019/08/manual-de-gesta%c3%87%c3%83ode-alto-risco-2011.pdf

Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet. 1999;353(9167):1829-33. https://doi.org/10.1016/S0140-6736(98)08220-8

Gomes ADO, Silva DAO, Silva NM, Barbosa BDF, Franco PS, Angeloni MB, et al. Effect of Macrophage Migration Inhibitory Factor (MIF) in Human Placental Explants Infected with Toxoplasma gondii Depends on Gestational Age. Am J Pathol. 2011;178(6):2792-801. https://doi.org/10.1016/j.ajpath.2011.02.005

Donadono V, Saccone G, Giuseppe MM, Berghella V, Migliorini S, Esposito G, et al. Incidence of toxoplasmosis in pregnancy in Campania: A population-based study on screening, treatment, and outcome. Eur J Obstet Gynecol Reprod Biol. 2019;240:316-21. https://doi.org/10.1016/j.ejogrb.2019.07.033

Paraná. Secretaria de Estado da Saúde. Caderno atenção ao pré-natal - Toxoplasmose [Internet]. Curitiba: Secretaria de Estado da Saúde [citado 2021 Jul 10]. Disponível em: http://www.sjp.pr.gov.br/wpcontent/uploads/2018/04/ANEXO-VII-toxoplasmosecong%C3%AAnita.pdf

Mandelbrot L, Winer N, Mesnard L, Berrebi A, Bory J, Ville Y, et al. Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial. Am J Obstet Gynecol. 2018;219:386. e1-9. https://doi.org/10.1016/j.ajog.2018.05.031

Published
2021-09-28
How to Cite
Righi, N. C., Hermes, L. ., Piccini, J. D., Branco, J. C., Skupien, J. A., Weinmann, A. R. M., Valadão, M. C. da S., & Schuch, N. J. (2021). Epidemiological profile of gestational and congenital toxoplasmosis cases arising out of the population outbreak. Scientia Medica, 31(1), e40108. https://doi.org/10.15448/1980-6108.2021.1.40108